All lobbying filings

RARE DISEASE COMPANY COALITION

Lobbying for RARE DISEASE COMPANY COALITION · Healthcare

Filing 1st Quarter - Amendment

1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate · $60,000.00 expenses · posted Apr 21, 2025

Official filing document

Bills named in this filing 6

HR 1262
Mikaela Naylon Give Kids a Chance Act
HR 946
ORPHAN Cures Act
HR 1414
Cameron’s Law
HR 1532
Scientific EXPERT Act of 2025
HR 7384
Creating Hope Reauthorization Act of 2024
HR 4758
Accelerating Kids’ Access to Care Act

Lobbying activity 3

Medicare/Medicaid

HR 4758 - Accelerating Kids Access to Care Act

Pharmacy

HR 1262 - Give Kids a Chance Act of 2025 S 932 - Give Kids a Chance Act of 2025 HR 946 - ORPHAN Cures Act S 3131 - ORPHAN Cures Act Technical Correction to IRA Orphan Exception HR 1414 - Camerons Law Orphan Drug Tax Credit HR 7384 - Creating Hope Reauthorization Act of 2024 S 4583 - Creating Hope Reauthorization Act of 2024

Science/Technology

HR 1532 - Scientific EXPERT Act of 2025 S 822 - Scientific EXPERT Act of 2025

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.